Today we explore the unique challenges and opportunities in Phase 1 ophthalmology clinical trials, focusing on gene therapy and inherited retinal diseases. 

Host: Amber Burg

Participants: David Hoelscher, Senior Medical Director, Ophthalmology 

Tanya Richardson, Therapeutic Strategy Head, Ophthalmology and Neuroscience